$ATR news
The latest ATR stock news: headlines, filings, AI summaries and sentiment for $ATR, updated around the clock.
- Purcell & Lefkowitz LLP Launches Shareholder Investigation into AptarGroup, Inc.
- Aptar Reports 5% Core Sales Growth in Q3 2026 Amid Pharmaceutical Expansion
- AptarGroup Reports Q3 2026 Sales Growth Amidst Margin Compression and Russian Deconsolidation
- AptarGroup Projects Q4 Adjusted EPS Growth Amid Declining Emergency Medicine Destocking
- APTARGROUP, INC. - 10-Q Filing
- AptarGroup Increases Quarterly Dividend to $0.50 Per Share
- AptarGroup Reports Q3 Earnings Beat with $1.02 Billion in Revenue
- APTARGROUP, INC. - 8-K Filing
- Aptar Pharma Acquires Pulmonary Drug Delivery Specialist Pulmotree
- APTARGROUP, INC. - 8-K Filing
- APTARGROUP, INC. - 8-K Filing
- AptarGroup Reports Record Q2 Sales but Faces EBITDA Margin Decline
- APTARGROUP, INC. - 8-K Filing
- AptarGroup Declares Quarterly Dividend of $0.48 Per Share
- APTARGROUP, INC. - 8-K Filing
- APTARGROUP, INC. - 8-K Filing
- AptarGroup (ATR) Reports Q1 2026 Earnings Results
- Boston Trust Walden Sells 93,512 Shares of Qualys (QLYS)